From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes
Metabolic modelling has been used to facilitate industrial microbiology projects and identify potential drug targets for the last 15 years. Although originally modest, the reliability of simulations has greatly improved by the progressive inclusion of chemical, biological and medical information in...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/72462/ |
| _version_ | 1848800743376551936 |
|---|---|
| author | Tomi Andrino, Claudio |
| author_facet | Tomi Andrino, Claudio |
| author_sort | Tomi Andrino, Claudio |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Metabolic modelling has been used to facilitate industrial microbiology projects and identify potential drug targets for the last 15 years. Although originally modest, the reliability of simulations has greatly improved by the progressive inclusion of chemical, biological and medical information in the models. While the multidisciplinary nature of systems biology entails rich and novel perspectives to solve problems, it is accompanied by a general lack of standardisation and consensus on methodology. Therefore, establishing robust workflows requires (i) assessing and comparing the predictive capabilities of current approaches against experimental data, and (ii) combining the strong points of different strategies to minimize their limitations and generate useful data in a timely manner.
In this study, metabolic networks for a bacterium, a parasite and a type of cancer were inspected by means of flux balance analysis and network analysis. Firstly, a readily available toolbox integrating thermodynamics information into flux balance analysis was modified to increase the number of physicochemical parameters including more suitable equations to physiological conditions. Thermodynamics constraints are closely related to the quantitation of metabolites in the cell. However, the lack of a “one size fits all” extraction and quantitation method prevents from performing a systems-wide analysis, forcing the researcher to select ca. 50 compounds for a targeted method. Exploring the topology of the network allowed identifying a set of important metabolites with a high constraining power, thus providing a rationale to such selection.
Secondly, metabolic modelling was used to facilitate drug repurposing efforts. There is a plethora of neglected diseases or conditions yet to be efficiently treated, so screening readily available drugs for novel uses has been deemed a cheaper and faster option than developing drugs from scratch. Therefore, systems biology has been exploited to reduce the list of potential candidates to be tested, as well as to identify novel potential drug targets. Specifically, a novel topological feature was introduced and combined with multiple metabolic states predicted by flux balance analysis in a model for the parasite causing sleeping sickness. Comparing against the literature validated the predictive capabilities of such approach and identified an antiviral whose potential lethality was tested in vitro.
Thirdly, a more information-rich workflow was developed based on the previous results. Transcriptomics data for a brain tumour was exploited to generate contextualised human metabolic models. Network analyses pinpointed important reactions and topological features of interest, greatly reducing the list of potential drug targets to be considered. Consequently, an automated search of chemical gene interactions and published results allowed identifying five compounds that had proven anti-proliferative and anti invasion effects on other cancer types. Finally, in vitro testing on patient-derived cancer cell lines showed their potential for further studies and generated new research questions.
This study provides considerations and approaches to increase the reliability of metabolic modelling predictions, as well as a novel workflow to identify relevant potential drug targets yet to be explored and prioritise chemicals to assess their suitability as drugs in a timely manner. |
| first_indexed | 2025-11-14T20:56:25Z |
| format | Thesis (University of Nottingham only) |
| id | nottingham-72462 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T20:56:25Z |
| publishDate | 2023 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-724622025-02-28T15:17:22Z https://eprints.nottingham.ac.uk/72462/ From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes Tomi Andrino, Claudio Metabolic modelling has been used to facilitate industrial microbiology projects and identify potential drug targets for the last 15 years. Although originally modest, the reliability of simulations has greatly improved by the progressive inclusion of chemical, biological and medical information in the models. While the multidisciplinary nature of systems biology entails rich and novel perspectives to solve problems, it is accompanied by a general lack of standardisation and consensus on methodology. Therefore, establishing robust workflows requires (i) assessing and comparing the predictive capabilities of current approaches against experimental data, and (ii) combining the strong points of different strategies to minimize their limitations and generate useful data in a timely manner. In this study, metabolic networks for a bacterium, a parasite and a type of cancer were inspected by means of flux balance analysis and network analysis. Firstly, a readily available toolbox integrating thermodynamics information into flux balance analysis was modified to increase the number of physicochemical parameters including more suitable equations to physiological conditions. Thermodynamics constraints are closely related to the quantitation of metabolites in the cell. However, the lack of a “one size fits all” extraction and quantitation method prevents from performing a systems-wide analysis, forcing the researcher to select ca. 50 compounds for a targeted method. Exploring the topology of the network allowed identifying a set of important metabolites with a high constraining power, thus providing a rationale to such selection. Secondly, metabolic modelling was used to facilitate drug repurposing efforts. There is a plethora of neglected diseases or conditions yet to be efficiently treated, so screening readily available drugs for novel uses has been deemed a cheaper and faster option than developing drugs from scratch. Therefore, systems biology has been exploited to reduce the list of potential candidates to be tested, as well as to identify novel potential drug targets. Specifically, a novel topological feature was introduced and combined with multiple metabolic states predicted by flux balance analysis in a model for the parasite causing sleeping sickness. Comparing against the literature validated the predictive capabilities of such approach and identified an antiviral whose potential lethality was tested in vitro. Thirdly, a more information-rich workflow was developed based on the previous results. Transcriptomics data for a brain tumour was exploited to generate contextualised human metabolic models. Network analyses pinpointed important reactions and topological features of interest, greatly reducing the list of potential drug targets to be considered. Consequently, an automated search of chemical gene interactions and published results allowed identifying five compounds that had proven anti-proliferative and anti invasion effects on other cancer types. Finally, in vitro testing on patient-derived cancer cell lines showed their potential for further studies and generated new research questions. This study provides considerations and approaches to increase the reliability of metabolic modelling predictions, as well as a novel workflow to identify relevant potential drug targets yet to be explored and prioritise chemicals to assess their suitability as drugs in a timely manner. 2023-03-15 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en cc_by https://eprints.nottingham.ac.uk/72462/2/From%20bacteria%20to%20cancer%20exploiting%20metabolic%20networks%20for%20industrial%20and%20therapeutic%20purposes.pdf Tomi Andrino, Claudio (2023) From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes. PhD thesis, University of Nottingham. metabolic modelling metabolic networks drug targeting |
| spellingShingle | metabolic modelling metabolic networks drug targeting Tomi Andrino, Claudio From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title | From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title_full | From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title_fullStr | From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title_full_unstemmed | From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title_short | From bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| title_sort | from bacteria to cancer exploiting metabolic networks for industrial and therapeutic purposes |
| topic | metabolic modelling metabolic networks drug targeting |
| url | https://eprints.nottingham.ac.uk/72462/ |